Objective: To establish parameters associated with successful fimbriectomy reversal and to estimate monthly fecundability and cumulative pregnancy rates through life-table analysis.
Design: Series report.
Setting: University-based infertility clinic.
Patient(s): Forty-one women undergoing surgery for tubal sterilization reversal.
Intervention(s): Surgical fimbriectomy reversal.
Main Outcome Measure(s): Time from sterilization to reversal, laparoscopy vs. laparotomy, uni- vs. bilateral fimbriectomy reversal, Bruhat vs. suture, tubal lengths, postsurgical hysterosalpingogram, ovulation induction, incidence of pregnancy and outcome, and life-table analysis to determine pregnancy rate.
Result(s): The mean time from sterilization to reversal was 11.5 years. Of the 41 women who underwent fimbriectomy reversal, 6 (14.6%) conceived. Sixteen reversals were performed by laparotomy resulting in 4 (25%) pregnancies, whereas 25 were performed laparoscopically resulting in 2 (8%) pregnancies. Eight had unilateral salpingostomies and 33 bilateral, of which 1 of 8 (12.5%) and 5 of 33 (15.2%) conceived, respectively. Using the Bruhat technique, 1 of 11 (9%) conceived vs. 5 of 30 (16.7%) that underwent reversal using sutures. The mean postoperative tubal length for the 6 women who conceived was 8 cm vs. 6.7 cm in the 35 women who did not conceive. Postoperatively, 26 women received ovulation induction and 1 (3.8%) conceived whereas 5 (33.3%) conceptions occurred in 15 women who did not require ovulation induction. Using life-table analysis with 619 postsurgical cycles, the monthly fecundability was.0097. The cumulative conception rate after 5 years was 31.2%.
Conclusion(s): Neosalpingostomy for the reversal of fimbriectomy sterilization represents a viable option for fertility restoration. The best candidates for this procedure are spontaneously ovulatory and have a tubal length of more than 7 cm.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0015-0282(01)02855-2 | DOI Listing |
NEJM Evid
September 2024
DuPont Clinic and Department of Population, Family, and Reproductive Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore.
Open Access J Contracept
May 2024
Department of Obstetrics and Gynaecology, Faculty of Medicine and Health Sciences, University of Stellenbosch, Tygerberg Hospital Francie van Zyl Dr, Cape Town, South Africa.
Womens Health Rep (New Rochelle)
April 2024
Department of Obstetrics, Gynecology and Women's Health, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, New York, USA.
Contraception
September 2024
Division of Family Planning, Obstetrics/Gynecology and Women's Health Institute, Cleveland Clinic, Cleveland, OH, United States.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!